Miyamoto, S.; Tanaka, T.; Hirosuna, K.; Nishie, R.; Ueda, S.; Hashida, S.; Terada, S.; Konishi, H.; Kogata, Y.; Taniguchi, K.;
et al. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization. Cancers 2022, 14, 2969.
https://doi.org/10.3390/cancers14122969
AMA Style
Miyamoto S, Tanaka T, Hirosuna K, Nishie R, Ueda S, Hashida S, Terada S, Konishi H, Kogata Y, Taniguchi K,
et al. Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization. Cancers. 2022; 14(12):2969.
https://doi.org/10.3390/cancers14122969
Chicago/Turabian Style
Miyamoto, Shunsuke, Tomohito Tanaka, Kensuke Hirosuna, Ruri Nishie, Shoko Ueda, Sousuke Hashida, Shinichi Terada, Hiromi Konishi, Yuhei Kogata, Kohei Taniguchi,
and et al. 2022. "Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization" Cancers 14, no. 12: 2969.
https://doi.org/10.3390/cancers14122969
APA Style
Miyamoto, S., Tanaka, T., Hirosuna, K., Nishie, R., Ueda, S., Hashida, S., Terada, S., Konishi, H., Kogata, Y., Taniguchi, K., Komura, K., & Ohmichi, M.
(2022). Validation of a Patient-Derived Xenograft Model for Cervical Cancer Based on Genomic and Phenotypic Characterization. Cancers, 14(12), 2969.
https://doi.org/10.3390/cancers14122969
